glp-1 landscape The expanding of medicines The Growing GLP-1 Market Landscape

doi: 10.1515/jbcpp-2018-0075 130

[4] [5] Maintenance therapy is typically 1 mg every 23 months for life

Heart failure and risk of dementia and Alzheimer disease: a population-based cohort study

Current multi-society guidance updated in 2024 suggests many patients can continue their GLP-1 medication around surgery using a risk-based plan, rather than an automatic stop

Your real options become: Coverage through sleep apnea or diabetes Switching plans during open enrollment Self-pay Bottom line: Individual plans follow strict state rules

To get started, create a volunteer profile, or contact [email protected], or call +18779788343 for more information